Atlas Venture Associates IX, LLC - Q1 2021 holdings

$595 Million is the total value of Atlas Venture Associates IX, LLC's 7 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .

 Value Shares↓ Weighting
SKLZ SellSKILLZ INC$437,214,000
-6.1%
22,962,910
-1.4%
73.46%
-0.5%
NTLA SellINTELLIA THERAPEUTICS INC$89,359,000
+1.7%
1,113,376
-31.1%
15.01%
+7.8%
SURF  SURFACE ONCOLOGY INC$22,974,000
-15.6%
2,945,4530.0%3.86%
-10.5%
SPRO  SPERO THERAPEUTICS INC$20,269,000
-24.1%
1,376,9680.0%3.40%
-19.5%
SYBX  SYNLOGIC INC$9,495,000
+65.8%
2,651,9630.0%1.60%
+75.7%
COGT BuyCOGENT BIOSCIENCES INC$8,050,000
-21.8%
916,832
+0.1%
1.35%
-17.1%
SNAP  SNAP INCcl a$7,852,000
+4.4%
150,1600.0%1.32%
+10.7%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INTELLIA THERAPEUTICS INC28Q3 2023100.0%
SNAP INC26Q3 202311.4%
SPERO THERAPEUTICS INC24Q3 202324.0%
SYNLOGIC INC24Q2 202335.6%
SURFACE ONCOLOGY INC21Q2 202333.3%
SKILLZ INC12Q3 202387.5%
UNUM THERAPEUTICS INC11Q3 202028.2%
COGENT BIOSCIENCES INC7Q2 20229.6%
CARBON BLACK INC6Q3 20197.8%
COHERUS BIOSCIENCES INC1Q3 202318.1%

View Atlas Venture Associates IX, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-08
13F-HR2023-01-31
13F-HR2022-11-10
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-01-27
13F-HR2021-11-04
13F-HR2021-08-11

View Atlas Venture Associates IX, LLC's complete filings history.

Compare quarters

Export Atlas Venture Associates IX, LLC's holdings